MedPath

iTBS Can Increase Frontal Dopamine Release in PET Dopamine Imaging.

Not Applicable
Conditions
Schizophrenia
Interventions
Device: Theta burst stimulation
Registration Number
NCT05448430
Lead Sponsor
Central South University
Brief Summary

Aim: 1. To confirm that patients with predominant negative symptoms in schizophrenia have deficits in frontal cortical dopamine release when compared with healthy control and patients with positive symptoms.

2. Our previous study found patients with negative symptoms have more possibilities to have disorders in glucose metabolism, we wonder whether dopamine release, negative symptoms or glucose metabolism can be improved by iTBS.

Study design: Case control study.

Detailed Description

Eligibility Criteria: Predominant negative symptoms for Positive and Negative Syndrome Scale factor score for negative symptoms of 24 or more, and score of 4 or more on at least two of three core negative PANSS items, PANSS for positive symptoms of 19 or less, HAMD depression scale of 16 or less. Predominant positive symptoms for PANSS for positive symptoms of 20 or more. Healthy control will be recruited matching the age and sex of patient groups, Outcome Measures: Oral glucose tolerance test (OGTT), PET dopamine imaging.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria
  • drug or alcohol addiction
  • diagnosed with other major mental disorders according to ICD-10 or DSM-V

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
predominant negative symptomsTheta burst stimulationiTBS for predominant negative symptoms
Primary Outcome Measures
NameTimeMethod
PET dopamine imaging and OGTTimmediate

PET dopamine imaging and OGTT after iTBS

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Central South University

🇨🇳

Changsha, Hunan, China

© Copyright 2025. All Rights Reserved by MedPath